Antibacterial activity of Lawsonia inermis Linn (Henna) against Pseudomonas aeruginosa

Asian Pacific Journal of Tropical Biomedicine

Volumn 1, Issue 3, 2011, Pages 173-176

  Habbal, O ^a   Hasson, S S ^a   El Hag, A H ^a   Al Mahrooqi, Z ^a   Al Hashmi, N ^a   Al Bimani, Z ^a   Al Balushi, M S ^a   Al Jabri, A A ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Antibacterial activity; Antibiotic susceptibility; Bacterial strain; Clinical isolate; Crude extract; Henna; Lawsonia inermis Linn; Micro organism; Oman; Pseudomonas aeruginosa

Indexed keywords

ALCOHOL; AMPHOTERICIN B; AMPICILLIN; ANTIINFECTIVE AGENT; GENTAMICIN; LAWSONIA INERMIS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG SCREENING; IN VITRO STUDY; LAWSONIA INERMIS; NONHUMAN; OMAN; PLANT LEAF; PLANT SEED; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; BACTERIA; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PLANT;

ANTI-BACTERIAL AGENTS; BACTERIA; LAWSONIA PLANT; MICROBIAL SENSITIVITY TESTS; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; PSEUDOMONAS AERUGINOSA;

EID: 79953848053     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(11)60021-X     Document Type: Article

References (21)

1. Veesenmeyer JL, Hauser AR, Lisboa T, Rello J Pseudomonas aeruginosa virulence and therapy: evolving translational strategies. Crit Care Med 2009, 37:1826-1827.
2. González-Lamothe R, Mitchell G, Gattuso M, Moussa S, Malouin DF, Bouarab K Plant antimicrobial agents and their effects on plant and human pathogens. Int J Mol Sci 2009, 10(8):3400-3419.
3. Fessenden RJ, Fessenden JS Organic chemistry 1998, 134-141. Brooks/Cole Publishing Inc, California. 6th ed.
4. Habbal OA, Al-Jabri AA, El-Hag A, Al-Mahrooqi ZH, Al-Hashmi NA In vitro antimicrobial activity of Lawsonia inermis Linn (henna): a pilot study on the omani Henna. Saudi Med J 2005, 26:69-72.
5. Habbal OA, Al-Jabri AA, El-Hag AG Antimicrobial properties of Lawsonia inermis (henna): a review. Aust J Med Herbal 2007, 19:114-125.
6. Ali NA, Julich WD, Kusnick C, Lindequist U Screening of Yemeni medicinal plants for antibacterial and cytotoxic activities. J Ethnopharmacol 2001, 74:173-179.
7. Ali BH, Bashir AK, Tanira MO Anti-inflammatory, antipyretic, and analgesic effects of Lawsonia inermis L. (henna) in rats. Pharmacology 1995, 51:356-363.
8. Borade AS, Babasaheb NK, Shete RV A phytopharmacological review on Lawsonia inermis (Linn.). Int J Pharm Life Sci 2011, 2(1):536-541.
9. Rahmatullah M, Mukti IJ, Haque AKM, Fahmidul MD, Mollik AH, Parvin K, et al. An ethnobotanical survey and pharmacological evaluation of medicinal plants used by the Garo Tribal Community living in Netrakona district, Bangladesh. Adv Nat Appl Sci 2009, 3(3):402-418.
10. Hema R, Kumaravel S, Gomathi S, Sivasubramaniam C Gas chromatography-mass spectroscopic analysis of Lawsonia inermis leaves. New York Sci J 2010, 3(11):141-143.
11. Holder IA, Boyce ST Agar well diffusion assay testing of bacterial susceptibility to various antimicrobials in concentrations non-toxic for human cells in culture. Burns 1994, 20(5):426-429.
12. Rosenthal VD, Maki DG, Mehta A, Alvarez-Moreno C, Leblebicioglu H, Higuera F, et al. International nosocomial infection control consortium report, data summary for 2002-2007, issued January. Am J Infect Control 2008, 36:627-637.
13. De Sousa B, Russell P, Moir G Henna skin reaction. Plast Reconstr Surg 2003, 111:2487-2488.
14. Suárez C, Peña C, Tubau F, Gavaldà L, Manzur A, Dominguez MA, et al. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections. J Infect 2009, 58:285-290.
15. Nirmalan M, Baldwin J Anaesthetic implications of henna. Eur J Anaesthesiol 1997, 14:665-666.
16. Maekawa LE, Lamping R, Marcacci S, Maekawa MY, Nassri MRG, Koga-ITO CY Antimicrobial activity of chlorophyll-based solution on Candida albicans and Enterococcus faecalis. Revista Sul-Brasileira de Odontologia 2007, 4(2):37-40.
17. Smith L The present status of topical chlorophyll therapy. NY State J Med 1955, 55:2041-2050.
18. Scherer D, Kumar R Genetics of pigmentation in skin cancer-a review. Mutat Res 2010, 705(2):141-153.
19. Thastrup O, Knudsen JB, Lemmich JL, Winther K Inhibitions of human platelet aggregation by dihydropyrano- and dihydrofurano-coumarins, a new class of cAMP phosphodiesterase inhibitors. Biochem Pharmacol 1985, 34:2137-2140.
20. Tan AS, Berridge MV Differential effects of redox-cycling and arylating quinones on trans-plasma membrane electron transport. Biofactors 2008, 34(3):183-190.
21. Córdoba-Pedregosa MC, Villalba JM, González-Aragón D, Bello RI, Alcaín FJ Cellular density and cell type are the key factors in growth inhibition induced by 2,5bis [1-aziridinyl]-1,4 benzoquinone (DZQ). Anticancer Res 2006, (5A):3535-3540.